
BA
The Boeing Company
Commercial airplanes, defense systems, satellites, space launch vehicles. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
6
$2.90M
Insider Sales
15
$13.00M
Total Volume
$15.90M
21 transactions
Net Activity
$10.10M
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 82% of total transaction value.
- •Cluster buying: 4 unique insiders purchased shares, showing strong alignment.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •High accumulation: total purchase value exceeds $1M.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Pope Stephanie F
EVP, Pres, CEO, BCA
$3.08M total
McKenzie Howard E
Chief Engineer, EVP, ET, T
$2.46M total
Raymond David Christopher
EVP, Pres, CEO, BGS
$2.12M total
Buckley Mortimer J
Dir
$2.00M total
Amuluru Uma M
EVP, CHRO
$1.84M total
Quick Actions
BA has an insider buy conviction of 18%, compared to the Industrials sector buy average of 22%. BA ranks #2 in insider activity out of 2 tracked companies in its industry.
Over the last 90 days, corporate insiders at The Boeing Company (BA) engaged in a total of 21 transactions reported via SEC Form 4 filings. Among these, 6 were open-market purchases and 15 were sales. The total volume of insider trading reached $15.90M.
The net insider activity for BA shows a net selling bias of $10.10M. This activity represents a 18% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Pope Stephanie F (EVP, Pres, CEO, BCA), who traded 16.8K shares valued at $3.08M on May 1, 2025.
BA Stock Quote Price and Forecast
Boeing (BA) Faces Execution Pressure, Is The Stock Fully Valued?
Is Boeing Stock Priced Right Against Its Peers?
Boeing Stock Dips Monday: What’s Going On?
Boeing Is Down 25% This Year. What Will It Take to Get BA Stock Back to $200?
Boeing (NYSE:BA) Shares Down 2.9% - What's Next?
Related News & Analyst Reports
Read original insights and educational research covering The Boeing Company and the Aerospace & Defense sector.
The Quant Guide: Backtesting SEC Form 4 Cluster Buys for Alpha
A rigorous quantitative backtest of SEC Form 4 cluster buying activity, demonstrating how to isolate signal from noise and build portfolios that consistently outperform benchmarks.
The Y Combinator Spinoff Trade: Spotting Alpha in Post-Demo Day IPOs
Y Combinator alumni companies show distinctive insider liquidity patterns after IPO. This report maps Form 4 activity at YC-backed public companies to identify when founder and early-investor selling subsides and conviction buying begins.
Venture Spinoffs vs. Direct Listings: A Comparative Analysis of Insider Holding Trends
Venture-backed spinoffs and direct listings both skip traditional IPO underwriting, but their insider holding dynamics differ sharply. This study compares Form 4 patterns at spinoff-versus-direct-listing companies to identify which structure produces stronger alignment signals.
Evaluating a16z Web3 Spinoffs: Insider Activity in Tech Convergence Stocks
Andreessen Horowitz has backed dozens of Web3 startups that later went public. This report tracks board-member Form 4 activity at a16z-affiliated tech convergence companies to identify post-IPO insider conviction signals.
Tracking Insider Activity in Biotech: High Stakes and Hidden Signals
Biotech insiders possess unique asymmetric information, clinical results, FDA feedback, partnership negotiations. This guide explains how to track Form 4 activity at pre-commercial biotechs, what position sizes matter, and how to avoid false signals near data events.
Venture-Backed Biotech IPOs: Inside the 2026 Buying Spree
2026 saw a resurgence of venture-backed biotech IPOs, accompanied by unusually high post-lockup insider buying. This report documents the specific Form 4 cluster events, purchase sizes, and 90-day price performance across a dozen recent biotech offerings.
FAQs About The Boeing Company Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for BA.